Total Return chart Annexin Pharmaceuticals AB

Stocks

Market Closed - Nasdaq Stockholm 12:00:00 2026-08-24 EDT			5-day change	1st Jan Change
13.20 ^SEK	0.00%		+2.33%	-33.33%

08-21	Annexin Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-21	Annexin Pharmaceuticals Expands Study on Retinal Vein Occlusion Drug Candidate	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.